
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, to...
- July 08, 2025 05:00 AM PDT
- EODHD

Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its...
- July 08, 2025 05:00 AM PDT
- EODHD

Reddit stock price target raised to $151 from $120 at Baird
Investing.com - Baird raised its price target on Reddit (NYSE:RDDT) to $151.00 from $120.00 on Tuesday, while maintaining a Neutral rating on the stock. The social media platform, currently trading at...
- July 08, 2025 04:56 AM PDT
- EODHD

Meta Poaches Top AI Talent From Apple
Meta is hiring away top AI talent from Apple. Matthew Bloxham of Bloomberg Intelligence is on "Bloomberg Brief." View Comments
- July 08, 2025 04:51 AM PDT
- EODHD

Bitdu issues official statement: ‘Bitdu Pro App’ identified as fraudulent, unaffiliated
Leading global digital asset exchange Bitdu has issued an official clarification regarding the emergence of a deceptive application titled “Bitdu Pro App”, which falsely claims to represent the Bitdu platform. Based on user complaints and internal investigations, the app has been identified as a fraudulent third-party tool involved in scam activities that include withholding user […]
- July 08, 2025 04:47 AM PDT
- Invezz

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, July 08, 2025--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today anno...
- July 08, 2025 04:30 AM PDT
- EODHD

Upstream Bio begins phase 2 COPD trial for verekitug
WALTHAM, Mass. - Upstream Bio, Inc. (NASDAQ:UPB) has dosed the first patient in its Phase 2 clinical trial evaluating verekitug for chronic obstructive pulmonary disease (COPD), the company announced...
- July 08, 2025 04:21 AM PDT
- EODHD

Tariff Threat Against Brics Poses Risk to Dollar
The dollar was steady but Trump’s threat to slap an additional 10% tariff on countries aligning themselves with the Brics alliance poses a risk to the currency. Continue Reading View Comments
- July 08, 2025 04:16 AM PDT
- EODHD

Exxon, Chevron Stocks Slip. How Crude Prices Are Knocking Big Oil.
Exxon Mobil said its second-quarter earnings will take a hit. Shell has said its trading profit will be lower than thought. Continue Reading View Comments
- July 08, 2025 04:14 AM PDT
- EODHD

IBM rolls out new chips and servers, aims for simplified AI
By Stephen Nellis SAN FRANCISCO (Reuters) -International Business Machines on Tuesday announced a new line of data center chips and servers that it says will be more power-efficient than rivals and wi...
- July 08, 2025 04:05 AM PDT
- EODHD